Evidence map›Paper›PMID 38263433›Full record

ArticleLeukemia2024

Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts.

Jacob S Appelbaum, Andrew H Wei, Sumithra J Mandrekar, Ing S Tiong, Chong Chyn Chua, Tse-Chieh Teh, Chun Yew Fong, Stephen B Ting, Daniela Weber, Axel Benner and 19 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Leukemia, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Jacob S AppelbaumClinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.ORCID http://orcid.org/0000-0002-4362-7773
Andrew H WeiDepartment of Clinical Haematology, Peter MacCallum Cancer Centre, and Royal Melbourne Hospital, Melbourne, VIC, Australia.
Sumithra J MandrekarDepartment of Quantitative Health Sciences, Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN, USA.
Ing S TiongDepartment of Pathology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.ORCID http://orcid.org/0000-0001-7417-4343
Chong Chyn ChuaThe Malignant Haematology, Transplantation and Cellular Therapies Service, Alfred Hospital, Melbourne, VIC, Australia.
Tse-Chieh TehThe Malignant Haematology, Transplantation and Cellular Therapies Service, Alfred Hospital, Melbourne, VIC, Australia.
Chun Yew FongAustin Health, Melbourne, VIC, Australia.
Stephen B TingEastern Health, Box Hill Hospital and Monash University, Melbourne, VIC, Australia.ORCID http://orcid.org/0000-0001-7755-8326
Daniela WeberDepartment of Internal Medicine III, Ulm University Hospital, Ulm, Germany.
Axel BennerDivision of Biostatistics, German Cancer Research Center, Heidelberg, Germany.
Hannah HillClinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Maral SaadatiFreelance Statistician, Saadati Solutions, Ladenburg, Germany.
Jun YinDepartment of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL, USA.
Richard M StoneDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID http://orcid.org/0000-0002-7526-2633
Guillermo Garcia-ManeroDepartment of Leukemia, MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-3631-2482
Harry P ErbaDuke University Cancer Center, Durham, NC, USA.
Geoffrey L UyWashington University School of Medicine, St. Louis, MO, USA.
Guido MarcucciCity of Hope Comprehensive Cancer Center, Duarte, CA, USA.ORCID http://orcid.org/0000-0002-3983-5908
Richard A LarsonUniversity of Chicago, Chicago, IL, USA.ORCID http://orcid.org/0000-0001-9168-3203
Abin ThomasCentre for Trials Research, Cardiff University, Cardiff, UK.
Sylvie D FreemanInstitute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.ORCID http://orcid.org/0000-0003-1869-180X
Nuria Marquez AlmuinaCentre for Trials Research, Cardiff University, Cardiff, UK.
Konstanze DöhnerDepartment of Internal Medicine III, Ulm University Hospital, Ulm, Germany.
Ian ThomasCentre for Trials Research, Cardiff University, Cardiff, UK.
Nigel H RusselSchool of Medicine, Nottingham University, Nottingham, UK.
Hartmut DöhnerDepartment of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.ORCID http://orcid.org/0000-0003-2116-5536
Megan Othus *Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. mothus@fredhutch.org.ORCID http://orcid.org/0000-0001-8176-6371
Elihu H Estey *
Roland B Walter *Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.ORCID http://orcid.org/0000-0002-9268-3341

Funding

SWOG Network Group Operations Center of the NCTNU10CA180888 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI PRIMO N. LARA · 2014 to 2026
$152.1M
SWOG Statistics & Data Management Center complex - extension supplement for GY06U10CA180819 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Catherine M. Tangen · 2014 to 2026
$115.2M
Clinician Scientist in LeukemiaR50CA275927 · NCI · WASHINGTON UNIVERSITY · PI GEOFFREY L UY · 2023 to 2026
$531k
NCI NIH HHS R50 CA275927NCI NIH HHS U10 CA180819NCI NIH HHS U10 CA180888
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Leukemia, Myeloid, AcuteAntineoplastic Combined Chemotherapy ProtocolsHumansPathologic Complete ResponseRemission Induction

Identifiers

PMID38263433
PMCPMC10996038

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.